Cargando…

Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection

Pancreatic cancer is an aggressive malignancy with a poor prognosis. The disease and its treatment can cause significant nutritional impairments that often adversely impact patient quality of life (QOL). The pancreas has both exocrine and endocrine functions and, in the setting of cancer, both syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilliland, Taylor M., Villafane-Ferriol, Nicole, Shah, Kevin P., Shah, Rohan M., Tran Cao, Hop S., Massarweh, Nader N., Silberfein, Eric J., Choi, Eugene A., Hsu, Cary, McElhany, Amy L., Barakat, Omar, Fisher, William, Van Buren, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372906/
https://www.ncbi.nlm.nih.gov/pubmed/28272344
http://dx.doi.org/10.3390/nu9030243
_version_ 1782518715451965440
author Gilliland, Taylor M.
Villafane-Ferriol, Nicole
Shah, Kevin P.
Shah, Rohan M.
Tran Cao, Hop S.
Massarweh, Nader N.
Silberfein, Eric J.
Choi, Eugene A.
Hsu, Cary
McElhany, Amy L.
Barakat, Omar
Fisher, William
Van Buren, George
author_facet Gilliland, Taylor M.
Villafane-Ferriol, Nicole
Shah, Kevin P.
Shah, Rohan M.
Tran Cao, Hop S.
Massarweh, Nader N.
Silberfein, Eric J.
Choi, Eugene A.
Hsu, Cary
McElhany, Amy L.
Barakat, Omar
Fisher, William
Van Buren, George
author_sort Gilliland, Taylor M.
collection PubMed
description Pancreatic cancer is an aggressive malignancy with a poor prognosis. The disease and its treatment can cause significant nutritional impairments that often adversely impact patient quality of life (QOL). The pancreas has both exocrine and endocrine functions and, in the setting of cancer, both systems may be affected. Pancreatic exocrine insufficiency (PEI) manifests as weight loss and steatorrhea, while endocrine insufficiency may result in diabetes mellitus. Surgical resection, a central component of pancreatic cancer treatment, may induce or exacerbate these dysfunctions. Nutritional and metabolic dysfunctions in patients with pancreatic cancer lack characterization, and few guidelines exist for nutritional support in patients after surgical resection. We reviewed publications from the past two decades (1995–2016) addressing the nutritional and metabolic status of patients with pancreatic cancer, grouping them into status at the time of diagnosis, status at the time of resection, and status of nutritional support throughout the diagnosis and treatment of pancreatic cancer. Here, we summarize the results of these investigations and evaluate the effectiveness of various types of nutritional support in patients after pancreatectomy for pancreatic adenocarcinoma (PDAC). We outline the following conservative perioperative strategies to optimize patient outcomes and guide the care of these patients: (1) patients with albumin < 2.5 mg/dL or weight loss > 10% should postpone surgery and begin aggressive nutrition supplementation; (2) patients with albumin < 3 mg/dL or weight loss between 5% and 10% should have nutrition supplementation prior to surgery; (3) enteral nutrition (EN) should be preferred as a nutritional intervention over total parenteral nutrition (TPN) postoperatively; and, (4) a multidisciplinary approach should be used to allow for early detection of symptoms of endocrine and exocrine pancreatic insufficiency alongside implementation of appropriate treatment to improve the patient’s quality of life.
format Online
Article
Text
id pubmed-5372906
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-53729062017-04-05 Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection Gilliland, Taylor M. Villafane-Ferriol, Nicole Shah, Kevin P. Shah, Rohan M. Tran Cao, Hop S. Massarweh, Nader N. Silberfein, Eric J. Choi, Eugene A. Hsu, Cary McElhany, Amy L. Barakat, Omar Fisher, William Van Buren, George Nutrients Review Pancreatic cancer is an aggressive malignancy with a poor prognosis. The disease and its treatment can cause significant nutritional impairments that often adversely impact patient quality of life (QOL). The pancreas has both exocrine and endocrine functions and, in the setting of cancer, both systems may be affected. Pancreatic exocrine insufficiency (PEI) manifests as weight loss and steatorrhea, while endocrine insufficiency may result in diabetes mellitus. Surgical resection, a central component of pancreatic cancer treatment, may induce or exacerbate these dysfunctions. Nutritional and metabolic dysfunctions in patients with pancreatic cancer lack characterization, and few guidelines exist for nutritional support in patients after surgical resection. We reviewed publications from the past two decades (1995–2016) addressing the nutritional and metabolic status of patients with pancreatic cancer, grouping them into status at the time of diagnosis, status at the time of resection, and status of nutritional support throughout the diagnosis and treatment of pancreatic cancer. Here, we summarize the results of these investigations and evaluate the effectiveness of various types of nutritional support in patients after pancreatectomy for pancreatic adenocarcinoma (PDAC). We outline the following conservative perioperative strategies to optimize patient outcomes and guide the care of these patients: (1) patients with albumin < 2.5 mg/dL or weight loss > 10% should postpone surgery and begin aggressive nutrition supplementation; (2) patients with albumin < 3 mg/dL or weight loss between 5% and 10% should have nutrition supplementation prior to surgery; (3) enteral nutrition (EN) should be preferred as a nutritional intervention over total parenteral nutrition (TPN) postoperatively; and, (4) a multidisciplinary approach should be used to allow for early detection of symptoms of endocrine and exocrine pancreatic insufficiency alongside implementation of appropriate treatment to improve the patient’s quality of life. MDPI 2017-03-07 /pmc/articles/PMC5372906/ /pubmed/28272344 http://dx.doi.org/10.3390/nu9030243 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gilliland, Taylor M.
Villafane-Ferriol, Nicole
Shah, Kevin P.
Shah, Rohan M.
Tran Cao, Hop S.
Massarweh, Nader N.
Silberfein, Eric J.
Choi, Eugene A.
Hsu, Cary
McElhany, Amy L.
Barakat, Omar
Fisher, William
Van Buren, George
Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection
title Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection
title_full Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection
title_fullStr Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection
title_full_unstemmed Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection
title_short Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection
title_sort nutritional and metabolic derangements in pancreatic cancer and pancreatic resection
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372906/
https://www.ncbi.nlm.nih.gov/pubmed/28272344
http://dx.doi.org/10.3390/nu9030243
work_keys_str_mv AT gillilandtaylorm nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT villafaneferriolnicole nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT shahkevinp nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT shahrohanm nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT trancaohops nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT massarwehnadern nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT silberfeinericj nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT choieugenea nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT hsucary nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT mcelhanyamyl nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT barakatomar nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT fisherwilliam nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection
AT vanburengeorge nutritionalandmetabolicderangementsinpancreaticcancerandpancreaticresection